Procaps SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Procaps SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10937
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:コロンビア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Procaps SAS (Procaps) is a manufacturing and commercializing company that provides pharmaceutical forms. The company provides softigel products such as RX products, OTC products, natural products, omega 3 fish oils, gummies and veterinary products, among others. Its hospitalaria unit offers bioser, biotec, farmionni and vademecum products. Procaps provides services such as packing design, training for product managers and sales teams, marketing outline for medical sales representatives and dossiers for stability reports and product samples. The company caters to pharmaceutical, cosmetic, nutritional supplement industries, and others. It operates through its business units. Procaps is headquartered in Barranquilla, Colombia.

Procaps SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Procaps SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Procaps SAS, Medical Devices Deals, 2012 to YTD 2018 9
Procaps SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Procaps SAS, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
International Finance to Invest in Procaps 11
Partnerships 12
Ani Pharma Enters Into Co-Development Agreement With Sofgen Pharma For Oral Soft Gel Prescription Product 12
Licensing Agreements 13
OncBioMune Enters into Licensing Agreement with PROCAPS 13
Ani Pharma Enters Into Licensing Agreement With Sofgen Pharma For Oral Soft Gel Product 14
Procaps SAS – Key Competitors 15
Procaps SAS – Key Employees 16
Procaps SAS – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Affiliate 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Procaps SAS, Pharmaceuticals & Healthcare, Key Facts 2
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Procaps SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Procaps SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Procaps SAS, Medical Devices Deals, 2012 to YTD 2018 9
Procaps SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
International Finance to Invest in Procaps 11
Ani Pharma Enters Into Co-Development Agreement With Sofgen Pharma For Oral Soft Gel Prescription Product 12
OncBioMune Enters into Licensing Agreement with PROCAPS 13
Ani Pharma Enters Into Licensing Agreement With Sofgen Pharma For Oral Soft Gel Product 14
Procaps SAS, Key Competitors 15
Procaps SAS, Key Employees 16
Procaps SAS, Other Locations 17
Procaps SAS, Subsidiaries 17
Procaps SAS, Affiliate 18

List of Figures
Procaps SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Procaps SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Procaps SAS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Procaps SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Midatech Pharma Plc (MTPH)-医療機器分野:企業M&A・提携分析
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercialize oncology and other therapeutic products. The company’s products include gelclair, oravig, soltamox, zuplenz, ferralet 90 and aquoral. It conducts research and development programs in areas of oncology, …
  • Leviton Manufacturing Co., Inc.:企業のM&A・提携動向(エネルギー分野)
    Summary Leviton Manufacturing Co., Inc. (Leviton) is an electrical and electronic product manufacturer that offers electrical wiring devices, network and data center connectivity solutions, and lighting energy management systems for use in residential, commercial, and industrial buildings. The compa …
  • Proteomics International Laboratories Ltd (PIQ):製品パイプライン分析
    Summary Proteomics International Laboratories Ltd (Proteomics International), a wholly-owned subsidiary and trading name of PILL, is a medical technology company, which focuses on proteomics, the study of structure and function of proteins. The company harnesses its proprietary proteomics-based tech …
  • Alliance Healthcare Services, Inc. (AIQ):企業のM&A・提携動向(医療機器分野)
    Summary Alliance Healthcare Services, Inc. (Alliance Healthcare Services) is a provider of shared services and diagnostic imaging services. The company’s diagnostic imaging services include magnetic resonance imaging (MRI), positron emission tomography (PET) and computed tomography (CT). It offers i …
  • Precision Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Precision Biosciences Inc (Precision BioSciences) is a biotechnology company, which develops and commercializes gene therapy and cancer immunotherapy. The company focuses its ARCUS technology, a proprietary genome editing platform, which combines specificity and efficacy, on the development …
  • Ranbaxy Laboratories Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ranbaxy Laboratories Limited Me …
  • Drake and Scull International PJSC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Drake and Scull International P …
  • Bellicum Pharmaceuticals Inc (BLCM):製薬・医療:M&Aディール及び事業提携情報
    Summary Bellicum Pharmaceuticals, Inc. (Bellicum) is a clinical stage biopharmaceutical company, which is engaged in developing cellular immunotherapies for the treatment of cancer. The company develops its product candidates through its chemical induction of dimerization technology platforms in the …
  • A. Schulman, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' A. Schulman, Inc. Mergers and A …
  • Dusit Thani Public Company Limited:企業の戦略・SWOT・財務情報
    Dusit Thani Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Dusit Thani Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Homburg Invest, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Homburg Invest, Inc. Mergers an …
  • Sedia Biosciences Corp:製品パイプライン分析
    Summary Sedia Biosciences Corp (SBC) is a medical device company that offers diagnostic products. The company provides medical devices, diagnostic devices, HIV incidence products, rapid point of care assays and specimen collection devices. It also offers diagnostic products, epidemiological products …
  • E. I. du Pont de Nemours and Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' E. I. du Pont de Nemours and Co …
  • OpSec Security Group plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OpSec Security Group plc Merger …
  • Fuji Kosan Company, Ltd. (5009):企業概要、財務及び戦略的SWOT分析
    Summary Fuji Kosan Company, Ltd. (Fuji Kosan) is a petroleum product distributor. The company purchases and distributes fuel oil, asphalt, lubricants, of Green Products. Its fuel oil products include kerosene, light oil, bunker A, LSA heavy oil, and bunker C. Fuji Kosan’s automotive lubricants inclu …
  • Uptake Medical Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Uptake Medical Corporation Merg …
  • TaiMed Biologics Inc (4147):製薬・医療:M&Aディール及び事業提携情報
    Summary TaiMed Biologics Inc (TMB) is a biotechnology company that provides novel medicines for the prevention and treatment of viral infectious diseases. The company provides pipeline products such as TMB-355, TMB-607 and TMB-571, among others. It offers TMB-355 which is a proprietary humanized ant …
  • Transgene SA (TNG):企業財務及び戦略的SWOT分析
    Summary Transgene SA (Transgene) is a biopharmaceutical company that focuses on the discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company’s lead clinical stage programs include TG4010, which is intended for the treatment of non small cell lung cance …
  • Rompetrol Well Services S.A. (PTR):企業財務及び戦略的SWOT分析
    Summary Rompetrol Well Services S.A. (Rompetrol Well) is an oil and gas company that offers oilfield consulting and cementing services. The company’s services include nitrogen services, cementing, acidizing, sand control, tubular running services, testing services, slick-line services, tools rental, …
  • ACE Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ACE Limited Mergers and Acquisi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆